Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Document and Entity Information

v3.19.1
Document and Entity Information
12 Months Ended
Dec. 31, 2018
shares
Document And Entity Information  
Entity Registrant Name Can-Fite BioPharma Ltd.
Entity Central Index Key 0001536196
Trading Symbol canf
Document Type 20-F
Document Period End Date Dec. 31, 2018
Amendment Flag false
Current Fiscal Year End Date --12-31
Document Fiscal Period Focus FY
Document Fiscal Year Focus 2018
Is Entity a Well-known Seasoned Issuer No
Is Entity a Voluntary Filer No
Is Entity's Reporting Status Current Yes
Entity Filer Category Non-accelerated Filer
Entity Emerging Growth Company true
Entity Ex Transition Period false
Entity Shell Company false
Entity Common Stock, Shares Outstanding 40,399,290